|
Age (years)
|
64.7 ± 15.2
|
75.3 ± 10.7
|
<0.01
|
|
Male (n, %)
|
175 (68.4)
|
34 (68.0)
|
NS
|
|
Body mass index (kg/m2)
|
24.2 ± 4.5
|
22.1 ± 3.8
|
<0.01
|
|
Systolic blood pressure (mmHg)
|
134 ± 27
|
124 ± 32
|
0.03
|
|
Diastolic blood pressure (mmHg)
|
78 ± 19
|
70 ± 18
|
<0.01
|
|
Heart rate (/min)
|
85 ± 30
|
82 ± 25
|
NS
|
|
Ejection fraction (%)
|
51.6 ± 16.7
|
39.7 ± 20.1
|
<0.01
|
|
Diabetes mellitus (n, %)
|
86 (33.6)
|
21 (42.0)
|
NS
|
|
Dyslipidemia (n, %)
|
191 (74.6)
|
28 (56.0)
|
0.01
|
|
Hypertension (n, %)
|
174 (68.0)
|
34 (68.0%)
|
NS
|
|
Atrial fibrillation (n, %)
|
59 (23.1)
|
22 (44.0)
|
<0.01
|
|
Ischemic heart disease (n, %)
|
141 (55.1)
|
27 (54.0)
|
NS
|
|
Diagnosis
|
|
Acute decompensated heart failure (n, %)
|
71 (27.7)
|
34 (68.0)
|
<0.01
|
|
Acute coronary syndrome (n, %)
|
121 (47.3)
|
8 (16.0)
|
<0.01
|
|
Laboratory data
|
|
Total cholesterol (mg/dL)
|
172 ± 38
|
153 ± 27
|
<0.01
|
|
LDL-cholesterol (mg/dL)
|
105 ± 31
|
93 ± 21
|
0.03
|
|
HDL- cholesterol (mg/dL)
|
44 ± 14
|
42 ± 12
|
NS
|
|
Triglycerides (mg/dL)
|
116 ± 72
|
86 ± 39
|
0.01
|
|
eGFR (mL/min/1.73m2)
|
71.9 ± 27.4
|
45.4 ± 26.8
|
<0.01
|
|
Hemoglobin A1c (%)
|
6.2 ± 1.2
|
6.1 ± 0.8
|
NS
|
|
Total protein (g/dL)
|
6.6 ± 0.6
|
6.5 ± 0.6
|
NS
|
|
Albumin (g/dL)
|
3.8 ± 0.6
|
3.4 ± 0.5
|
<0.01
|
|
Brain natriuretic peptide (pg/mL)
|
490 ± 762
|
1443 ± 1357
|
<0.01
|
|
Medication
|
|
Diuretics (n, %)
|
45 (17.7)
|
29 (59.2)
|
<0.01
|
|
Antiplatelets (n, %)
|
95 (37.4)
|
25 (51.0)
|
NS
|
|
Anticoagulants (n, %)
|
39 (15.4)
|
22 (44.9)
|
<0.01
|
|
ACE-I/ARBs (n, %)
|
111 (43.7)
|
29 (59.2)
|
NS
|
|
β-blockers (n, %)
|
82 (32.3)
|
22 (44.9)
|
NS
|
|
Calcium channel blockers (n, %)
|
94 (37.0)
|
18 (36.7)
|
NS
|
|
Inotropic agents (n, %)
|
3 (1.2)
|
9 (18.4)
|
<0.01
|
|
Statins (n, %)
|
81 (31.9)
|
16 (32.7)
|
NS
|
|
Oral hypoglycemic agents (n, %)
|
45 (17.7)
|
9 (18.4)
|
NS
|
|
Insulin (n, %)
|
15 (5.9)
|
3 (6.1)
|
NS
|
